Cenegermin-bkbj 0.02 mg/ML
RxNorm 2104333
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2104333 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cenegermin-bkbj 0.02 mg/ML.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDCPrescribable
Semantic Clinical Drug Component (SCDC):
Cenegermin-bkbj 0.02 mg/ML
(Atom ID: 10779235)
Patient Education
Cenegermin-bkbj Ophthalmic
Ophthalmic cenegermin-bkbj is used to treat neurotrophic keratitis (a degenerative eye disease that can lead to damage of the cornea [the outermost layer of the eye]). Cenegermin-bkbj is in a class of medications called recombinant human nerve growth factors. It works to heal the cornea.
[Learn More]
* Please review the disclaimer below.